SCHEMBL7941599

SCHEMBL7941599

CN1CCCC1B(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25681729 0.77 — —
SCHEMBL14571345 0.71 DPP4 (0.42) —
SCHEMBL25054844 0.70 DPP4 (0.49) —
SCHEMBL8093802 0.70 DPP4 (0.45) —
SCHEMBL13248694 0.70 DPP4 (0.49) —
SCHEMBL15335279 0.69 FAP (0.63) —
SCHEMBL13371725 0.65 DPP4 (0.47) —
SCHEMBL13456720 0.65 — —
SCHEMBL20939371 0.65 CHRM2 (0.47) —
SCHEMBL487464 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021249566-A1 BENZO SIX-MEMBERED RING DERIVATIVE AND USE THEREOF 山东百极地长制药有限公司 2021-12-16 — — WO disclosed
EP-3214079-B1 SIX-MEMBERED RING BENZO DERIVATIVES AS DPP-4 INHIBITOR AND USE THEREOF UNIV EAST CHINA SCIENCE & TECH (CN) 2020-06-24 — — EP disclosed
US-10479798-B2 Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-11-19 — — US disclosed
US-20170313715-A1 SIX-MEMBERED RING BENZO DERIVATIVES AS DPP-4 INHIBITOR AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-11-02 — — US disclosed
US-20170313715-A1 SIX-MEMBERED RING BENZO DERIVATIVES AS DPP-4 INHIBITOR AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-11-02 — — US disclosed
EP-3214079-A1 SIX-MEMBERED RING BENZO DERIVATIVES AS DPP-4 INHIBITOR AND USE THEREOF East China University Of Science And Technology (CN) 2017-09-06 — — EP disclosed
US-20170028080-A1 Targeted Drug Conjugates PHILOCHEM AG (CH) 2017-02-02 — — US disclosed
US-20150202218-A1 Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus Infections TRUSTEES OF TUFTS COLLEGE 2015-07-23 — — US disclosed
US-20060063719-A1 Methods for treating diabetes POINT THERAPEUTICS, INC. (US) 2006-03-23 — — US disclosed
Send feedback